PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
Famotidine for Oral Suspension | 40mg/5mL |
![]() |
50mL |
68180-0150-01 |
Pepcid® |
AB |
Histamine H2-Receptor antagonist |
Fenofibrate Capsules | 43mg |
![]() |
30 |
68180-0130-06 |
Antara® |
AB |
Antihyperlipidemic |
Fenofibrate Tablets | 48mg |
![]() |
90 |
68180-388-09 |
Tricor® |
AB |
Antihyperlipidemic agent |
Fenofibrate Tablets | 54mg |
![]() |
90 |
68180-231-09 |
Lofibra® |
AB |
Antihyperlipidemic agent |
Flucytosine Capsules USP | 250 mg |
![]() |
100 |
43386-771-01 |
Ancobon® |
AB |
Antifungal |
Fluocinonide Topical Solution USP | 0.05% |
![]() |
20 mL |
43386-026-02 |
Lidex® |
AT |
Corticosteroid |
Fyavolv™ | 0.5mg/0.0025mg |
![]() |
28 x 3 |
68180-828-73 |
FemHRT® |
AB |
Hormone Replacement Therapy |
GaviLAX (PEG3350) Powder for Oral Solution | 17gm/scoopful |
![]() |
238g |
43386-312-14 |
MiraLAX® |
AA |
Laxative |
GaviLyteâ„¢ – C | 240 -5.84-2.98-6.72-22.72gm |
![]() |
4 L |
43386-060-19 |
Colyte® |
AA |
Hyperosmotic |
GaviLyteâ„¢ – G | 236-5.86-2.97-6.74-22.74 gm |
![]() |
4 L |
43386-090-19 |
GoLYTELY® |
AA |
Hyperosmotic |
GaviLyteâ„¢-N | 420-111.20-1.48-5.72 gm |
![]() |
4 L |
43386-050-19 |
NuLYTELY® |
AA |
Hyperosmotic |
Hydrocortisone Butyrate Lotion | 0.1% |
![]() |
59 mL |
68180-951-01 |
Locoid® |
AB |
Corticosteroid |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.